13 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... #Meningitis #Antibiotics ... #Antimicrobials ... InfectiousDiseases #Pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
Recommendations for specific antimicrobial ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial ... InfectiousDiseases #Pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Parenteral Antimicrobial ... #Parenteral #IV ... #Antibiotics #Osteomyelitis ... management #treatment #pharmacology ... #idsa
IDSA - Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Children
Initial empirical therapy
 • Amoxicillin-clavulanate (45 mg/kg/day
IDSA - Antimicrobial ... bid) Risk for antibiotic ... every 12–24 h) #Antimicrobial ... #Antibiotics #Bacterial ... Rhinosinusitis #IDSA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Enteric Illness: • Antimicrobial ... if MIC<0.12 ug/ml ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
IV Fluids - Comparison Table
Fluid - pH - Osm - Na - Cl - Other
 •
IV Fluids - Comparison ... pH - Osm - Na - Cl ... EmmGeezee #IV ... #Fluids #IVF #Comparison ... #Table #pharmacology
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
Antimicrobial Regimens ... qd) Risk for antibiotic ... #empiric #idsa ... #antibiotics #Bacterial ... Adults #management #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
metronidazole Antimicrobial ... (IV or PO?) ... If on IV, can I ... Susceptibilities #antibiotics ... #management #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... 400 mg) PO or IV ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology